Caption Management, LLC Ascendis Pharma A/S Call Options Transaction History

Caption Management, LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$113.0 - $153.43 $3.67 Million - $4.99 Million	32,500 New	32,500 $4.85 Million
Q3 2023 Nov 14, 2023	SELL	$86.5 - $103.97 $10.1 Million - $12.2 Million	-117,200 Reduced 81.84%	26,000 $2.43 Million
Q2 2023 Aug 14, 2023	SELL	$69.96 - $97.84 $22.1 Million - $31 Million	-316,400 Reduced 68.84%	143,200 $12.8 Million
Q1 2023 May 15, 2023	BUY	$104.9 - $126.78 $31.5 Million - $38.1 Million	300,400 Added 188.69%	459,600 $49.3 Million
Q4 2022 Feb 14, 2023	SELL	$99.42 - $131.97 $48.6 Million - $64.5 Million	-488,800 Reduced 75.43%	159,200 $19.4 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $54.5 Million - $71.4 Million	648,000 New	648,000 $66.9 Million
Q3 2021 Nov 12, 2021	BUY	$112.67 - $176.92 $788,690 - $1.24 Million	7,000 Added 53.85%	20,000 $3.19 Million
Q2 2021 Aug 16, 2021	SELL	$121.62 - $145.29 $851,340 - $1.02 Million	-7,000 Reduced 35.0%	13,000 $1.71 Million
Q1 2021 May 17, 2021	BUY	$124.92 - $173.33 $2.5 Million - $3.47 Million	20,000 New	20,000 $2.58 Million
Q1 2020 May 15, 2020	SELL	$97.01 - $145.11 $6.02 Million - $9.01 Million	-62,100 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$91.45 - $139.12 $3.85 Million - $5.86 Million	42,100 Added 210.5%	62,100 $8.64 Million
Q2 2019 Aug 13, 2019	SELL	$107.11 - $132.09 $14.3 Million - $17.7 Million	-133,800 Reduced 87.0%	20,000 $2.3 Million
Q1 2019 May 14, 2019	BUY	$62.15 - $129.99 $9.56 Million - $20 Million	153,800 New	153,800 $18.1 Million

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.